Gallbladder Cancer: Why Are COVID-19 mRNA Vaccinated Getting These Types of Turbo Cancers?

Gallbladder Turbo Cancer (10 cases)
According to Schoenmaker et al (2021), the Pfizer and Moderna mRNA vaccines have Lipid Nanoparticles LNPs that are 60 to 100nm in size.
From Banoun et al (2022): “Excretion of PEG-coated LNPs is primarily through feces and urine and primarily through feces (hepatobiliary) when they are > 80 nm in diameter.”
A large portion of the Pfizer & Moderna Lipid Nanoparticles (with mRNA) that get into the bloodstream are cleared by the liver and the hepatobiliary system.
You can see this in Pfizer’s own biodistribution studies:

As the Pfizer & Moderna Lipid Nanoparticles are cleared by the liver, they end up in the intrahepatic bile ducts, gallbladder, common bile duct, pancreas, small bowel and large bowel (and are eliminated in feces).
In this article you see a completely different demographic (ages 30s, 40s, 50s) with completely different tumor behaviour (death in months, surgery failure, chemotherapy failure, rapid growth, large tumors, aggressive metastasis, etc)
I believe these Hepatobiliary Turbo Cancers may be happening, in part, due to the LNP/mRNA clearance through the hepatobiliary system.
It is possible that cells of the hepatobiliary system are being transfected with Pfizer & Moderna LNP/mRNA with unforeseen long term consequences.
In Parts 2 and 3 I will cover Turbo Cancers of the Pancreas and the Colon.
*
Note to readers: Please click the share button above. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.
Dr. William Makis is a Canadian physician with expertise in Radiology, Oncology and Immunology. Governor General’s Medal, University of Toronto Scholar. Author of 100+ peer-reviewed medical publications.



















